DXCM vs. CRM
DXCM (DexCom, Inc.) and CRM (Salesforce, Inc.) are both stocks. DXCM operates in Diagnostics & Research (Healthcare), while CRM operates in Software - Application (Technology). Over the past 10 years, DXCM returned 15.17%/yr vs 7.60%/yr for CRM. At a 0.35 correlation, their price movements are largely independent.
Performance
DXCM vs. CRM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, DXCM achieves a 13.56% return, which is significantly higher than CRM's -37.06% return. Over the past 10 years, DXCM has outperformed CRM with an annualized return of 15.17%, while CRM has yielded a comparatively lower 7.60% annualized return.
DXCM
- 1D
- 0.16%
- 1M
- 28.68%
- YTD
- 13.56%
- 6M
- 12.56%
- 1Y
- -9.03%
- 3Y*
- -15.73%
- 5Y*
- -5.51%
- 10Y*
- 15.17%
CRM
- 1D
- -0.34%
- 1M
- 0.29%
- YTD
- -37.06%
- 6M
- -36.31%
- 1Y
- -37.22%
- 3Y*
- -6.88%
- 5Y*
- -6.82%
- 10Y*
- 7.60%
DXCM vs. CRM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
DXCM DexCom, Inc. | 13.56% | -14.66% | -37.33% | 9.58% | -15.64% | 45.23% | 69.02% | 82.59% | 108.75% | -3.87% |
CRM Salesforce, Inc. | -37.06% | -20.25% | 27.76% | 98.46% | -47.83% | 14.20% | 36.82% | 18.74% | 33.98% | 49.33% |
Correlation
The correlation between DXCM and CRM is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.19 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.27 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.37 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.39 |
Correlation (All Time) Calculated using the full available price history since Apr 14, 2005 | 0.35 |
The correlation between DXCM and CRM shifts across timeframes, from 0.19 (1 year) to 0.39 (10 years), reflecting how their relationship changes across market environments.
Fundamentals
DXCM:
$29.67B
CRM:
$144.49B
DXCM:
$2.31
CRM:
$8.59
DXCM:
32.57
CRM:
19.31
DXCM:
0.77
CRM:
0.04
DXCM:
6.29
CRM:
3.62
DXCM:
10.03
CRM:
4.22
DXCM:
$4.82B
CRM:
$42.83B
DXCM:
$2.96B
CRM:
$33.25B
DXCM:
$1.37B
CRM:
$12.32B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DXCM vs. CRM — Risk / Return Rank
DXCM
CRM
DXCM vs. CRM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for DexCom, Inc. (DXCM) and Salesforce, Inc. (CRM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| DXCM | CRM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.76 | ||
| Sortino ratioReturn per unit of downside risk | +1.34 | ||
| Omega ratioGain probability vs. loss probability | 1.00 | 0.84 | +0.16 |
| Calmar ratioReturn relative to maximum drawdown | -0.23 | -0.95 | +0.71 |
| Martin ratioReturn relative to average drawdown | -0.40 | -1.78 | +1.38 |
Loading charts...
Drawdowns
DXCM vs. CRM - Drawdown Comparison
The maximum DXCM drawdown since its inception was -94.61%, which is greater than CRM's maximum drawdown of -70.50%. Use the drawdown chart below to compare losses from any high point for DXCM and CRM.
Loading charts...
Drawdown Indicators
| DXCM | CRM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.61% | -70.50% | -24.11% |
Max Drawdown (1Y)Largest decline over 1 year | -38.75% | -39.36% | +0.61% |
Max Drawdown (3Y)Largest decline over 3 years | -60.95% | -54.70% | -6.25% |
Max Drawdown (5Y)Largest decline over 5 years | -66.32% | -58.62% | -7.70% |
Max Drawdown (10Y)Largest decline over 10 years | -66.32% | -58.62% | -7.70% |
Current DrawdownCurrent decline from peak | -53.71% | -54.33% | +0.62% |
Average DrawdownAverage peak-to-trough decline | -36.02% | -16.15% | -19.87% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 22.77% | 20.92% | +1.85% |
Volatility
DXCM vs. CRM - Volatility Comparison
The current volatility for DexCom, Inc. (DXCM) is 13.27%, while Salesforce, Inc. (CRM) has a volatility of 16.76%. This indicates that DXCM experiences smaller price fluctuations and is considered to be less risky than CRM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DXCM | CRM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.27% | 16.76% | -3.49% |
Volatility (6M)Calculated over the trailing 6-month period | 25.48% | 31.59% | -6.11% |
Volatility (1Y)Calculated over the trailing 1-year period | 40.74% | 38.09% | +2.65% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 46.98% | 37.07% | +9.91% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 48.43% | 35.38% | +13.05% |
Dividends
DXCM vs. CRM - Dividend Comparison
DXCM has not paid dividends to shareholders, while CRM's dividend yield for the trailing twelve months is around 1.28%.
| Position | TTM | 2025 | 2024 |
|---|---|---|---|
CRM Salesforce, Inc. | 1.28% | 0.63% | 0.48% |
DXCM DexCom, Inc. | 0.00% | 0.00% | 0.00% |
Financials
DXCM vs. CRM - Financials Comparison
This section allows you to compare key financial metrics between DexCom, Inc. and Salesforce, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
DXCM vs. CRM - Profitability Comparison
DXCM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, DexCom, Inc. reported a gross profit of 750.30M and revenue of 1.19B. Therefore, the gross margin over that period was 63.0%.
CRM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Salesforce, Inc. reported a gross profit of 8.56B and revenue of 11.13B. Therefore, the gross margin over that period was 76.9%.
DXCM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, DexCom, Inc. reported an operating income of 255.30M and revenue of 1.19B, resulting in an operating margin of 21.4%.
CRM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Salesforce, Inc. reported an operating income of 2.35B and revenue of 11.13B, resulting in an operating margin of 21.1%.
DXCM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, DexCom, Inc. reported a net income of 199.50M and revenue of 1.19B, resulting in a net margin of 16.7%.
CRM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Salesforce, Inc. reported a net income of 2.11B and revenue of 11.13B, resulting in a net margin of 18.9%.
Frequently Asked Questions
DXCM and CRM have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CRM has higher volatility (16.76%) compared to DXCM (13.27%). In terms of maximum drawdown, DXCM dropped -94.61% vs CRM's -70.50%.
DXCM currently has the higher Sharpe Ratio (-0.22 vs -0.98), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for DXCM and CRM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer